OCTOBER 2024 I MAZE THERAPEUTICS
American Society of Nephrology Kidney Week 2024 | Limb et al.Safety, Tolerability, and Pharmacokinetics of MZE829, an APOL1 Inhibitor, in Healthy Adult Volunteers
Safety, Tolerability, and Pharmacokinetics of MZE829, an APOL1 Inhibitor, in Healthy Adult Volunteers